We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
(-4.3%)
Cap. Flow
-$587M
Cap. Flow
% of AUM
-4.35%
Top 10 Holdings %
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$30.1M |
| 2 |
Energy Transfer Partners
ET
|
+$24.7M |
| 3 |
Franklin FTSE Japan ETF
FLJP
|
+$11.8M |
| 4 |
Wells Fargo
WFC
|
+$9.66M |
| 5 |
Alkermes
ALKS
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$49.8M |
| 2 |
Enterprise Products Partners
EPD
|
+$49.1M |
| 3 |
Western Midstream Partners
WES
|
+$44.8M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$42.5M |
| 5 |
EQM
EQM Midstream Partners, LP
EQM
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.41% |
| 2 | Financials | 7.05% |
| 3 | Healthcare | 3.6% |
| 4 | Consumer Discretionary | 3.1% |
| 5 | Technology | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Blackstone
BX
$104B
| $1.32M | 0.01% |
29,700
-237,200
| -89% | -$9.46M |
|
277
Cognizant
CTSH
$21.5B
| $1.3M | 0.01% |
20,571
-42
| -0.2% | -$2.76K |
|
278
H&R Block
HRB
$5.18B
| $1.29M | 0.01% |
44,175
-9,785
| -18% | -$263K |
|
279
Agilent Technologies
A
$39.1B
| $1.27M | 0.01% |
17,047
+1,455
| +9% | +$108K |
|
280
Navient
NAVI
$774M
| $1.27M | 0.01% |
92,862
-21,167
| -19% | -$276K |
|
281
Crinetics Pharmaceuticals
CRNX
$8.86B
| $1.26M | 0.01% |
+50,525
| New | +$1.25M |
|
282
Commault Systems
CVLT
$5.89B
| $1.26M | 0.01% |
25,404
+6,249
| +33% | +$332K |
|
283
Matsons
MATX
$6.37B
| $1.26M | 0.01% |
32,363
-2,568
| -7% | -$97.1K |
|
284
Louisiana-Pacific
LPX
$5.2B
| $1.25M | 0.01% |
47,865
-1,606
| -3% | -$39.4K |
|
285
Viking Therapeutics
VKTX
$4.04B
| $1.25M | 0.01% |
150,810
-21,793
| -13% | -$186K |
|
286
Krystal Biotech
KRYS
$9.88B
| $1.22M | 0.01% |
30,228
-4,623
| -13% | -$151K |
|
287
Gartner
IT
$9.41B
| $1.21M | 0.01% |
7,525
+725
| +11% | +$113K |
|
288
Celanese
CE
$5.09B
| $1.21M | 0.01% |
11,214
-331
| -3% | -$34.3K |
|
289
Anika Therapeutics
ANIK
$199M
| $1.21M | 0.01% |
+29,735
| New | +$1.08M |
|
|
REGI
290
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.2M | 0.01% |
75,541
+29,012
| +62% | +$535K |
|
291
Dianthus Therapeutics
DNTH
$5.68B
| $1.19M | 0.01% |
+5,042
| New | +$1.25M |
|
292
KKR & Co
KKR
$89.2B
| $1.19M | 0.01% |
47,100
-368,100
| -89% | -$8.81M |
|
293
Pultegroup
PHM
$24.5B
| $1.19M | 0.01% |
37,540
-453
| -1% | -$14.1K |
|
294
Edwards Lifesciences
EW
$47.6B
| $1.18M | 0.01% |
19,113
-2,304
| -11% | -$139K |
|
295
ICICI Bank
IBN
$106B
| $1.17M | 0.01% |
92,945
+22,450
| +32% | +$260K |
|
|
AGN
296
DELISTED
Allergan plc
AGN
| $1.16M | 0.01% |
6,938
+292
| +4% | +$40.4K |
|
297
Charter Communications
CHTR
$14.7B
| $1.16M | 0.01% |
2,929
-910
| -24% | -$341K |
|
298
Expeditors International
EXPD
$22.9B
| $1.16M | 0.01% |
15,239
-264
| -2% | -$19.9K |
|
|
ANSS
299
DELISTED
Ansys
ANSS
| $1.16M | 0.01% |
5,637
+490
| +10% | +$93.4K |
|
300
Everest Group
EG
$15.2B
| $1.14M | 0.01% |
4,604
-5,214
| -53% | -$1.25M |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.
- ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
- ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
- ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
- ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
- ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
- ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
- ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.
Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.